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Abstract 
BACKGROUND: The growing needs to extract cardiovascular implantable electronic devices warrants the need 
to improve the outcome and prevent complications. 
AIM: This study aims to analyse the findings and identify factors associated with complications of Percutaneous 
Transvenous Lead Extraction in the Critical Care Department, Cairo University. 
METHODS: We studied 52 candidates for Percutaneous Transvenous Lead extraction of a Permanent Pace 
Maker (PPM) regarding extraction indications, comorbidities, device type, complications and outcome. Extraction 
was first attempted by simple manual traction using regular non-locking stylet and if failed, locking stylet, and 
evolution dilator sheath were used. 
RESULTS: We extracted 110 leads with a mean lead age of 4.67 ± 3.6 years. The most common extraction 
indication was an infection (71.15%). Indications correlated significantly with comorbidities (p = 0.024), the most 
common being Diabetes Mellitus (40.38%). Simple traction was successful in 31 % of the leads, while 69% were 
extracted using locking stylet and evolution dilator sheath. The method of lead extraction correlated significantly 
with lead age (P ≤ 0.001). Complications were significantly higher with extraction by evolution dilator sheaths than 
by simple traction (P = 0.003) and in older patients (P = 0.008). Complications also correlated significantly with 
extractions indications (p = 0.012), type of PPM (P = 0.037), number of extracted leads (P = 0.041), and lead age 
(p= 0.011).  
CONCLUSION: Among the studied variables, extraction indications particularly infection, was the only 
preventable factor significantly associated with complications. While focusing on preventable factors, improving, 
implantation and extraction techniques should also be addressed. 
 
 
 
 
 
 
Introduction 
 
In recent years, the number of Cardiac 
Implantable Electronic Device (CIED) complications 
has increased as a result of the increasing 
implantations. Concomitantly a rise in lead 
malfunctions and recalls accompanying the complex 
CIED procedures in high-risk patients has resulted in 
increased Transvenous Lead Extractions (TLE) [1], 
[2], [3], [4], [5]. Lead extraction is by far a complex 
procedure as it carries some risks for the patient [6], 
[7].  
Age, sex, body mass index, lead implant 
duration, number of leads, even small calcifications or 
fibrosis along with the lead, venous thrombosis, 
systemic infection, presence of large vegetations, 
pacemaker dependency, and physical characteristics 
of the lead, e.g. intrinsic fragility are all factors 
associated with increased procedural risk. Infections, 
lead malfunction, actual or potential lead failure, 
interference between multiple leads, lead-induced life-
threatening arrhythmias, lead interference with 
malignancy treatment, chronic pain and subclavian 
vein/superior vena cava thrombosis are clinical 
situations most commonly requiring lead extraction to 
be completely alleviated [6], [7].  
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Methods 
 
From March 2016 to February 2018, 52 
candidates for percutaneous Transvenous Lead 
Extractions (TLE) of Cardiac Implantable Electronic 
Devices (CIED), were enrolled in a prospective study 
conducted in Critical Care Department in Kasr Al-Ainy 
Hospital, Cairo University, Egypt. We aimed to 
analyse the findings and identify factors associated 
and can be predictive of complications of 
Percutaneous Transvenous Lead Extraction. 
Patients were enrolled in the current study 
according to the Heart Rhythm Society (HRS) 
indications (2009) for lead extraction classes I & IIa
 
[7]. All patients had undergone full medical history 
taking, body mass index (BMI) assessment, recording 
of indication, type, and functional status of CIED and 
indication of lead extraction. All patients were also 
subjected to full clinical examination & investigations 
in the form of full laboratory tests including blood 
culture and sensitivity, wound swab and blood typing, 
12-lead surface ECG, Chest x-ray, Trans-thoracic 
echocardiography (TTE). Transesophageal 
echocardiography (TEE) was performed in every 
patient with suspected CIED-related infection to 
assess vegetations’ place and size if present (Figure 
1). 
 
Figure 1: A patient with infective endocarditis secondary to pocket 
infection. A: TEE showing two large masses (bold arrows) attached 
to the pacemaker lead, B: A closed sinus of infected pocket and 
leads extrusion before extraction in our study  
 
Lead extraction procedure 
Following the induction of anaesthesia, proper 
skin preparation and sterile draping of the patient, a 
Temporary Pacing Lead was placed in the right 
ventricle via the right femoral vein. Invasive arterial 
blood pressure monitoring was connected via the right 
radial artery. Local anaesthesia and incision at the site 
of the pocket were done under deep sedation and 
analgesics. Extraction of the battery was done if 
present. Stylet wires were used to stiffen leads for 
removal and minimising the chance of lead breakage 
during traction and assist sheath advancement, which 
results in the extraction of a greater amount of intact 
lead. Simple traction Technique was initially tried for 
all patients in which manipulation of the lead was 
done so that the lead exits the vasculature via the 
implant vein using tools typically supplied for the lead 
implant, with the addition of traction. If the simple 
traction failed, traction with the help of Locking stylets 
and Evolution mechanical dilator sheath was 
attempted. A locking stylet is a special type of a 
traction device, designed to hold onto the inside of the 
conductor coil along its length or near the distal 
stimulating electrode. It improves the tensile 
properties and prevents elongation of the lead body 
during traction. We used Liberator (Cook Vascular) 
locking stylet.  
Finally, after extraction of all leads, complete 
removal of all granulation tissue and necrotic material 
was done with adequate haemostasis and closure of 
the wound by properly interrupted suture. 
Patients were kept postoperatively in the 
Cardiac Care Unit (CCU) under strict monitoring of 
vital signs, haematocrit and other labs with the 
adequate replacement of any blood loss during or 
after the procedure. Post-procedure chest X-ray & 
TTE were done within a few hours to detect any 
complications of TLE, e.g. pericardial effusion. Proper 
antibiotic therapy was instituted, and revision of the 
need for CIED reimplantation was done. 
Procedure success was classified as; (1) 
Complete procedural success: if all targeted leads and 
lead material were removed from the vascular space, 
(2) Clinical success: if all targeted leads and lead 
material was removed, but with retention of a small 
portion of the lead that does not negatively affect 
outcome goals, or (3) Failure: if neither complete 
procedural nor clinical success could be achieved
(7)
. 
Complications were classified into Intraprocedural: 
Any event related to the performance of the procedure 
that occurs or becomes evident in the Cath. Lab. 
Postprocedural: Any event related to the procedure 
that occurs or becomes evident within the 30 days 
following the procedure. Events are classified as 
major or minor according to severity: Major 
complications: Those that create a life-threatening 
situation or require a major intervention for their 
resolution or result in death, e.g. cardiac avulsion and 
vascular tear requiring surgical repair. Then Minor 
complications: not life-threatening, but require an 
intervention, such as medication, for their resolution, 
e.g. pericardial effusion not requiring 
pericardiocentesis.  
The study was approved by the ethical 
committee of the critical care department, Cairo 
University. Written informed consent was signed by 
the patient or his/her family. 
 
Statistical Analysis 
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 24. Data were summarised 
using mean, standard deviation, median, minimum 
and maximum in quantitative data and using 
frequency (count) and relative frequency (percentage) 
for categorical data. Comparison between quantitative 
variables was made using the non-parametric 
Kruskal-Wallis and Mann-Whitney tests [8]. For 
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comparing categorical data, Chi-square (
2
) test was 
performed. Exact test was used instead when the 
expected frequency is less than 5 [9]. P-values less 
than 0.05 were considered as statistically significant. 
 
 
Results 
 
In total, 52 patients were included in our 
study; the baseline characteristics were shown in 
Table 1. Thirty-one males (59.6%) and 21 females 
(40.4%) with a mean age of 53.5 ± 14.1 years, the 
mean left ventricular ejection fraction (LVEF) was 51.7 
± 13.4%. The mean Body Mass Index (BMI) was 
26.04 ± 3.95. Indications for TLE were infective in 37 
patients (71.15%) and non-infective in 15 patients 
(28.85%). A total of 110 leads were extracted via the 
venous entry approach from 52 patients with a mean 
number of leads extracted per patient was 2.1. They 
included 106 pacing leads (96.36%) and 4 shock 
leads with dual coils (3.64%). 
Table 1: Demographic and descriptive characteristics 
Item Number (%) 
Age (mean) 53.56 ± 14.12 
Sex Male 
Female 
31 (59.6%) 
21 (40.4%) 
Left Ventricle EF% 51.73 ± 13.47 
Body Mass Index (mean) 26.04 ± 3.95 
Indications Infective indications 37 (71.15%) 
Pocket infection 26 (50%) 
Infective Endocarditis 11 (21.15%) 
Non-infective indications 15 (28.85%) 
Lead malfunction 7 (13.46%) 
Lead displacement or extrusion 5 (9.61%) 
Upgrading 3 (5.76%) 
Type of implanted 
device 
DDD 33 (63.5%) 
CRT-P 10 (19.2%) 
CRT-D 4 (7.7%) 
VVI 5 (9.6%) 
Leads implanted Total 110 
Active fixation 88 (80%) 
Passive fixation 22 (20%) 
Atrial leads 44 (40%) 
RV leads 48 (43.64%) 
Coronary sinus 14 (12.73%) 
Shock leads 4 (3.63%) 
Extraction Technique Simple traction 34 (31%) 
Evolution traction 76 (69%) 
Mean implant duration (years) 4.67 ± 3.61 
Mean procedure duration (minutes) 81.73 ± 38.4 
 
Fixation mechanisms did not affect the 
method of TLE and its outcome. The method of the 
lead extraction showed a statistically significant 
relationship with the lead implant duration (P-value < 
0.001) as shown in Table 2, where simple traction was 
more successful with shorter lead age. Also, the 
longer the leads’ age, the longer was the procedure 
duration with a P-value of < 0.001. 
Table 2: Method of extraction vs lead age 
 Method of extraction P-value 
Simple Traction Evolution 
Mean SD Mean SD 
Lead age 
(years) 
1.53 1.80 6.48 3.11 < 0.001 
 
 
In our study, complications of TLE occurred in 
28 patients (53.8%) and most of them were minor 
complications and managed conservatively and only 
one major complication (subclavian vein tear) which 
required surgical repair by a vascular surgeon. 
The most common complication was 
hematoma formation in the pocket site (21.1%) and 
managed by proper compression and medical 
treatment after vascular surgery consultation. Patients 
with mild and moderate pericardial effusion (26.9%) 
were managed conservatively without the need for 
tapping. In our study, the rate of occurrence of 
complications was more in older age with a P-value 
0.008 where the mean age in the complicated patients 
was 58.43 ± 11.1 years, and the mean age in the non-
complicated patients was 47.88 ± 15.25 years. The 
rate of complications showed statistically significant 
difference according to the method of extraction 
where complications were more in Evolution method 
with a P-value 0.003, as shown in Table 3.  
Table 3: Complications 
Parameter 
Complications 
P 
yes No 
Extraction 
indications 
Pocket Infection N (%) 14 (53.8%) 12 (46.2%) 
0.012 
Infective endocarditis N (%) 10 (90.9%) 1 (9.1%) 
Upgrade to ICD N (%) 1 (50.0%) 1 (50.0%) 
Upgrade to CRT-D N (%) 1 (100%) 0 (0%) 
Not connected old Lead 
extrusion N (%) 
0 (0%) 1 (100%) 
Malfunctioning RV lead N (%) 1 (20.0%) 4 (80 %) 
Malfunctioning atrial lead N (%) 0 (0%) 2 (100%) 
Lead displacement N (%) 1 (25.0%) 3 (75.0%) 
Patient’s Age (Mean± standard deviation) 58.43 ±11.19 47.88±15.25 0.008 
Lead Age (Mean± standard deviation) 5.73 ± 3.47 3.44 ± 3.44 0.011 
Method of extraction 
Simple Traction N (%) 5 (26.3%) 14 (73.7%)  
0.003 Evolution Method N (%) 23 (69.7%) 10 (30.3%) 
Type of PPM 
VVI N (%) 2 (40.0%) 3 (60.0%) 
0.037 
DDD N (%) 14 (42.4%) 19 (57.6%) 
CRT-P N (%) 8 (80.0%) 2 (20.0%) 
CRT-D N (%) 4 (100.0%) 0 (0 %) 
No. of extracted 
leads 
1 N (%) 4 (36.4%) 7 (63.6%) 
0.041 
2 N (%) 11 (44.0%) 14 (56.0%) 
3 N (%) 12 (80.0%) 3 (20.0%) 
4 N (%) 1 (100%) 0 (0%) 
 
The number of extracted leads was directly 
proportional to the occurrence of complications with a 
P-value 0.041. There was a statistically significant 
difference regarding the occurrence of complications 
and the type of CIED and the extracted leads (P-value 
0.037), where the percentage of complications in the 
form of subclavian vein tear, pericardial effusion and 
hematoma formation was more with extraction of 
shock leads in CRT-D devices due to presence of 
large and thick fibrous bands at shock lead binding 
sites, e.g. SVC coil as shown in Table 3. Our study 
showed that longer lead implant duration (lead age) 
reflects a higher incidence of complications of TLE 
with a P-value 0.011, as shown in Table 3. 
Regarding procedure success, clinical 
success was achieved in all patients (52 patients) 
while complete procedure success (radiological and 
clinical) was achieved in 48 patients (92.3%) where a 
retained part of RV lead occurred in 4 patients (7.7%) 
and did not affect the patient outcome.  
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Discussion 
 
In a European survey conducted by the 
European Heart Rhythm Association (EHRA) in 2012, 
the success rates and complications of TLE 
techniques showed that TLE was still under-
developed across European countries with divergent 
practices between centres [3], [10]. In our Critical 
Care Department, Cairo University, the rate of CIED 
implantation increased over the years. This increase 
in rate was associated with increased risk of 
complications requiring TLE, especially with multiple 
generator replacements. 
Many studies have been done in the last 10 
years on CIED lead extraction techniques. Regarding 
indications of TLE, the most common indications of 
extraction in our patients were infection in 71.15% of 
patients (50% local and 21.15 % lead vegetations) 
while indications were non-infective in 28.85% of 
patients. In agreement with our study, Andrzej et al., 
[11], also found that the most common indication for 
TLE was an infection. Similarly, indications of 
extraction in Stylianos P et al., [12] study was an 
infection in 69.4% of the patients and led dysfunction 
in 30.6% of the patients. While in the EHRA survey
 
2012, the infection was the indication in 70% of the 
patients and non-infective indications in 30% of the 
patients [10]. In ELECTRa, the infection was the 
indication in 52.8% of the patients and non-infective 
indications in 47.2% of the patients [10]. On the other 
hand, in Oto et al., [13] study in Turkey, the 
indications for lead extraction were primarily due to 
lead malfunction in 65.2% of the patients, cardiac 
device infection only in 30.4% of the patients and lead 
displacement in 4.4% of the patients.  
In our study, there was no effect of lead 
fixation mechanisms on the method of extraction or 
the outcome of the procedure, only the Andrzej et al., 
the study stated that modern leads with active fixation 
could be easily extracted by traction [11].  
The method of lead extraction showed a 
statistically significant relationship with the age of the 
lead (P-value < 0.001). The more the age of lead 
implantation; the more the difficulty of extraction by 
simple traction technique and the leads were 
extracted by locking stylet and evolution dilator 
sheath.  
In Andrzej et al., [11] study, 19.5% of leads 
were removed by simple traction while other leads 
(80.5 %) were removed using the Lead Extraction 
System with the rotational cutting force only, with no 
laser or RF energy. In three cases in which breakage 
of the lead occurred, the remaining part of the broken 
lead was removed via a femoral approach.  
Byrd et al.,
 
[14] reported that incomplete / 
failed extraction was more likely to occur in younger 
patients as the extent and quality of the scar tissue 
formed around the leads are inversely related to the 
age. However, our study failed to express this relation 
as younger patients were not significantly represented 
in our cohort (P-value 0.171). 
In our study, older leads were associated with 
significantly prolonged procedure time compared to 
other leads (P-value < 0.001) and associated with a 
higher incidence of complications of TLE with a P-
value 0.011 with no effect on patient outcome. 
However, Stylianos et al., a study [12], [15] noted that 
lead age per se did not hurt lead extraction success 
rate or occurrence of complications.  
Regarding complications of TLE, they 
occurred in 28 patients (53.8%) and most of them 
were minor complications and managed by 
conservative measures, the most common was 
hematoma formation (21.15% of patients), mild and 
moderate pericardial effusion and retained parts of 
leads and only one major complication (1.9% of 
patients) in which subclavian vein tear occurred and 
required surgical repair by a vascular surgeon. In 
Andrzej et al., a study [11], major complications 
occurred in 4 % of patients in the form of massive 
pericardial effusion, massive pulmonary embolism and 
papillary muscle rupture. While in Oto et al., [13] 
study, minor complications occurred in 4.3 % of 
patients in the form of a hematoma. While in the 
EHRA survey [10],
 
all 81 centres revealed major 
complications in their experience, where 10% of the 
centres experienced a death rate of 0.5-2% of 
patients. Other major complications like massive 
pericardial effusion requiring pericardiocentesis, 
vascular avulsion and hemothorax requiring chest 
tube, occurred in about 1-5 % of patients in all 
centres. In our study, the rate of occurrence of 
complications showed a statistically significant 
relationship with the type of CIED and the extracted 
leads (P-Value 0.037), where complications in the 
form of moderate pericardial effusion, subclavian vein 
tear and hematoma formation were more with the 
extraction of shock leads in CRT-D devices.  
Our procedure success rate was high and 
comparable to other centres and in comparison, with 
the other studies, our rate and type of complications 
were relatively less, in spite of the relatively new 
experience of different methods of extraction in our 
department and restricted budget. This was most 
probably attributed to the good patient preoperative 
preparation and the skilled operator technique who 
was trained in a large centre of extraction in Europe.  
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